Physician profile
Christina Valsamis
NPI 1851614473
$2,268.12
in general payments reported to CMS, 2019-2025
17 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 88% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.43 · 2022: $97.64 · 2023: $212 · 2024: $874 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,139.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $503.26 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $262.95 | 2022-2025 | Fasenra, Tezspire |
| Harmony Biosciences LLC | $250.04 | 2023-2025 | Wakix |
| Electromed, INC. | $185.79 | 2022-2025 | Smartvest |
| Inspire Medical Systems, INC. | $185.13 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $154.91 | 2024-2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $129.88 | 2022-2025 | Nucala, Trelegy Ellipta |
| Baxter Healthcare | $128.26 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $121.16 | 2019-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $91.59 | 2022-2025 | |
| Verona Pharma, INC. | $82.07 | 2025 | Ohtuvayre |
| Amgen INC. | $55.86 | 2024 | Tezspire |
| Jazz Pharmaceuticals INC. | $29.56 | 2024 | |
| Axsome Therapeutics, INC. | $27.78 | 2025 | Sunosi |
| Resmed Corp | $26.37 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $18.50 | 2025 | Alvesco |
| 3b Medical, INC. | $15.01 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Valsamis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.